|
1
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: from genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Llovet JM and Bruix J: Molecular targeted
therapies in hepatocellular carcinoma. Hepatology. 48:1312–1327.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lodige I, Marg A, Wiesner B, Malecova B,
Oelgeschlager T and Vinkemeier U: Nuclear export determines the
cytokine sensitivity of STAT transcription factors. J Biol Chem.
280:43087–43099. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mowen K and David M: Regulation of STAT1
nuclear export by Jak1. Mol Cell Biol. 20:7273–7281. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khodarev NN, Minn AJ, Efimova EV, et al:
Signal transducer and activator of transcription 1 regulates both
cytotoxic and prosurvival functions in tumor cells. Cancer Res.
67:9214–9220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bromberg JF, Horvath CM, Wen Z, Schreiber
RD and Darnell JE Jr: Transcriptionally active Stat1 is required
for the antiproliferative effects of both interferon α and
interferon γ. Proc Natl Acad Sci USA. 93:7673–7678. 1996.PubMed/NCBI
|
|
7
|
Shankaran V, Ikeda H, Bruce AT, White JM,
Swanson PE, Old LJ and Schreiber RD: IFNγ and lymphocytes prevent
primary tumour development and shape tumour immunogenicity. Nature.
410:1107–1111. 2001.
|
|
8
|
Osna NA, Clemens DL and Donohue TM Jr:
Ethanol metabolism alters interferon gamma signaling in recombinant
HepG2 cells. Hepatology. 42:1109–1117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin W, Choe WH, Hiasa Y, Kamegaya Y,
Blackard JT, Schmidt EV and Chung RT: Hepatitis C virus expression
suppresses interferon signaling by degrading STAT1.
Gastroenterology. 128:1034–1041. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bromberg J and Darnell JE Jr: The role of
STATs in transcriptional control and their impact on cellular
function. Oncogene. 19:2468–2473. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu H and Jove R: The STATs of cancer - new
molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Levy DE and Darnell JE Jr: Stats:
transcriptional control and biological impact. Nat Rev Mol Cell
Biol. 3:651–662. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Samuel CE: Antiviral actions of
interferons. Clin Microbiol Rev. 14:778–809. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Balasubramanian A, Ganju RK and Groopman
JE: Signal transducer and activator of transcription factor 1
mediates apoptosis induced by hepatitis C virus and HIV envelope
proteins in hepatocytes. J Infect Dis. 194:670–681. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chawla-Sarkar M, Lindner DJ, Liu YF,
Williams BR, Sen GC, Silverman RH and Borden EC: Apoptosis and
interferons: role of interferon-stimulated genes as mediators of
apoptosis. Apoptosis. 8:237–249. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xi S, Dyer KF, Kimak M, et al: Decreased
STAT1 expression by promoter methylation in squamous cell
carcinogenesis. J Natl Cancer Inst. 98:181–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Calvisi DF, Ladu S, Gorden A, et al:
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Gastroenterology. 130:1117–1128. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee CK, Smith E, Gimeno R, Gertner R and
Levy DE: STAT1 affects lymphocyte survival and proliferation
partially independent of its role downstream of IFN-γ. J Immunol.
164:1286–1292. 2000.PubMed/NCBI
|
|
19
|
Nguyen H, Lin R and Hiscott J: Activation
of multiple growth regulatory genes following inducible expression
of IRF-1 or IRF/RelA fusion proteins. Oncogene. 15:1425–1435. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sironi JJ and Ouchi T: STAT1-induced
apoptosis is mediated by caspases 2, 3, and 7. J Biol Chem.
279:4066–4074. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Knoblich JA, Sauer K, Jones L, Richardson
H, Saint R and Lehner CF: Cyclin E controls S phase progression and
its down-regulation during Drosophila embryogenesis is
required for the arrest of cell proliferation. Cell. 77:107–120.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kortylewski M, Komyod W, Kauffmann ME,
Bosserhoff A, Heinrich PC and Behrmann I: Interferon-γ-mediated
growth regulation of melanoma cells: involvement of STAT1-dependent
and STAT1-independent signals. J Invest Dermatol. 122:414–422.
2004.
|
|
23
|
Bressac B, Galvin KM, Liang TJ,
Isselbacher KJ, Wands JR and Ozturk M: Abnormal structure and
expression of p53 gene in human hepatocellular carcinoma. Proc Natl
Acad Sci USA. 87:1973–1977. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sheahan S, Bellamy CO, Dunbar DR, Harrison
DJ and Prost S: Deficiency of G1 regulators P53, P21Cip1
and/or pRb decreases hepatocyte sensitivity to TGFβ cell cycle
arrest. BMC Cancer. 7:2152007.PubMed/NCBI
|
